These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33983108)

  • 1. Depressive symptoms in early alcohol or opioid abstinence: course & correlates.
    Sapkota P; Mattoo SK; Mahintamani T; Ghosh A
    J Addict Dis; 2022; 40(1):35-46. PubMed ID: 33983108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation and characteristics of self-rating and clinically rating depression among alcoholics in the course of early abstinence.
    Mandić-Gajić G; Samardžić R; Špirić Ž
    Vojnosanit Pregl; 2015 May; 72(5):437-41. PubMed ID: 26165052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender Differences in Affects and Craving in Alcohol-Dependence: A Study During Alcohol Detoxification.
    Petit G; Luminet O; Cordovil de Sousa Uva M; Monhonval P; Leclercq S; Spilliaert Q; Zammit F; Maurage P; de Timary P
    Alcohol Clin Exp Res; 2017 Feb; 41(2):421-431. PubMed ID: 28060415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Craving and Depressive Symptoms in Ketamine-Dependent Patients Undergoing Withdrawal Treatment.
    Chen LY; Chen CK; Chen CH; Chang HM; Huang MC; Xu K
    Am J Addict; 2020 Jan; 29(1):43-50. PubMed ID: 31691402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between depression and the dexamethasone suppression test following alcohol withdrawal in a psychiatric population.
    Johnson B; Perry JC
    J Clin Psychopharmacol; 1986 Dec; 6(6):343-9. PubMed ID: 3805327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single high-dose buprenorphine for opioid craving during withdrawal.
    Ahmadi J; Jahromi MS; Ghahremani D; London ED
    Trials; 2018 Dec; 19(1):675. PubMed ID: 30526648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of sequential fluoxetine and gender on prequit depressive symptoms, affect, craving, and quit day abstinence in smokers with elevated depressive symptoms: a growth curve modeling approach.
    Minami H; Kahler CW; Bloom EL; Prince MA; Abrantes AM; Strong DR; Niaura R; Miller IW; Palm Reed KM; Price LH; Brown RA
    Exp Clin Psychopharmacol; 2014 Oct; 22(5):392-406. PubMed ID: 25089930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of PDYN 68-bp VNTR polymorphism with sublingual buprenorphine/naloxone treatment and with opioid or alcohol use disorder: Effect on craving, depression, anxiety and age onset of first use.
    Kaya-Akyüzlü D; Özkan-Kotiloğlu S; Yalçın-Şahiner Ş; Ağtaş-Ertan E; Özgür-İlhan İ
    Eur J Pharmacol; 2022 Apr; 921():174862. PubMed ID: 35271823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anxiety and depressive symptoms and affective patterns of tobacco withdrawal.
    Leventhal AM; Ameringer KJ; Osborn E; Zvolensky MJ; Langdon KJ
    Drug Alcohol Depend; 2013 Dec; 133(2):324-9. PubMed ID: 23896304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quetiapine decreases alcohol consumption, craving, and psychiatric symptoms in dually diagnosed alcoholics.
    Martinotti G; Andreoli S; Di Nicola M; Di Giannantonio M; Sarchiapone M; Janiri L
    Hum Psychopharmacol; 2008 Jul; 23(5):417-24. PubMed ID: 18425995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of depressive symptoms on future alcohol use in patients with co-occurring bipolar disorder and alcohol dependence: a prospective analysis in an 8-week randomized controlled trial of acamprosate.
    Prisciandaro JJ; DeSantis SM; Chiuzan C; Brown DG; Brady KT; Tolliver BK
    Alcohol Clin Exp Res; 2012 Mar; 36(3):490-6. PubMed ID: 21933201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scopolamine detoxification technique for heroin dependence: a randomized trial.
    Liu S; Li L; Shen W; Shen X; Yang G; Zhou W
    CNS Drugs; 2013 Dec; 27(12):1093-102. PubMed ID: 24092568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Childhood neglect and increased withdrawal and depressive severity in crack cocaine users during early abstinence.
    Francke ID; Viola TW; Tractenberg SG; Grassi-Oliveira R
    Child Abuse Negl; 2013 Oct; 37(10):883-9. PubMed ID: 23988085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How soon can we identify at-risk patients: examining initial depressive symptomology and opioid use in musculoskeletal trauma survivors?
    Sharififar S; Gupta S; Vincent HK; Vasilopoulos T; Zdziarski-Horodyski L; Horodyski M; Hagen JE
    Injury; 2020 Jul; 51(7):1543-1547. PubMed ID: 32430191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlates of depressive symptoms among alcohol-using methadone maintained adults.
    Nyamathi A; Albarrán CR; Branson C; Marfisee M; Khalilifard F; Leake B
    Am J Addict; 2012 Nov; 21 Suppl 1(0 1):S49-55. PubMed ID: 23786510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agitated depression in substance dependence.
    Leventhal AM; Gelernter J; Oslin D; Anton RF; Farrer LA; Kranzler HR
    Drug Alcohol Depend; 2011 Jul; 116(1-3):163-9. PubMed ID: 21277711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of outcome for short-term medically supervised opioid withdrawal during a randomized, multicenter trial of buprenorphine-naloxone and clonidine in the NIDA clinical trials network drug and alcohol dependence.
    Ziedonis DM; Amass L; Steinberg M; Woody G; Krejci J; Annon JJ; Cohen AJ; Waite-O'Brien N; Stine SM; McCarty D; Reid MS; Brown LS; Maslansky R; Winhusen T; Babcock D; Brigham G; Muir J; Orr D; Buchan BJ; Horton T; Ling W
    Drug Alcohol Depend; 2009 Jan; 99(1-3):28-36. PubMed ID: 18805656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of baseline depressive symptoms in the development of depressive episode in patients receiving antiviral therapy for hepatitis C infection.
    Mahajan S; Avasthi A; Grover S; Chawla YK
    J Psychosom Res; 2014 Aug; 77(2):109-15. PubMed ID: 25077851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential risk factors associated with risk for drop-out and relapse during and following withdrawal of opioid prescription medication.
    Heiwe S; Lönnquist I; Källmén H
    Eur J Pain; 2011 Oct; 15(9):966-70. PubMed ID: 21546290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.